BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35355750)

  • 1. Evaluation of the Association of Transferrin Receptor Type 2 Gene Mutation (Y250X) with Iron Overload in Major β- Thalassemia.
    Abdulmalek Jaafar J; Al-Rashedi NAM
    Arch Razi Inst; 2021 Nov; 76(5):1551-1554. PubMed ID: 35355750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin receptor-2 gene and non-C282Y homozygous patients with hemochromatosis.
    Aguilar-Martinez P; Esculié-Coste C; Bismuth M; Giansily-Blaizot M; Larrey D; Schved JF
    Blood Cells Mol Dis; 2001; 27(1):290-3. PubMed ID: 11358390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy.
    Zarghamian P; Azarkeivan A; Arabkhazaeli A; Mardani A; Shahabi M
    BMC Med Genet; 2020 Apr; 21(1):75. PubMed ID: 32268883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of hepcidin gene expression in blood mononuclear cells with iron overload severity among β-thalassemia major patients.
    Ayatollahi H; Mousavi Nezhad SF; Talebpour A; Badiei Z; Nezami H
    Mol Biol Rep; 2020 Dec; 47(12):9353-9359. PubMed ID: 33231816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of iron overload in a cohort of Sri Lankan patients with transfusion dependent beta thalassaemia and its correlation with pathogenic variants in HBB, HFE, SLC40A1, and TFR2 genes.
    Dissanayake R; Samarasinghe N; Waidyanatha S; Pathirana S; Neththikumara N; Dissanayake VHW; Wetthasinghe K; Gooneratne L; Wickramasinghe P
    BMC Pediatr; 2022 Jun; 22(1):344. PubMed ID: 35705926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overload.
    Barton EH; West PA; Rivers CA; Barton JC; Acton RT
    Blood Cells Mol Dis; 2001; 27(1):279-84. PubMed ID: 11358388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
    Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
    Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of correlation between H63D and C282Y mutations in HFE gene and serum Ferritin level in beta-thalassemia major patients.
    Rahmani R; Naseri P; Safaroghli-Azar A; Tarighi S; Hosseini T; Hojjati MT
    Transfus Clin Biol; 2019 Nov; 26(4):249-252. PubMed ID: 31679808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers.
    Melis MA; Cau M; Deidda F; Barella S; Cao A; Galanello R
    Haematologica; 2002 Mar; 87(3):242-5. PubMed ID: 11869934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of TfR2-Y250X and TfR1- rs3817672 Single Nucleotide Polymorphism on Pathophysiology of Iron Deficiency Anemia.
    Pandey S; Pandey SK; Shah V
    J Assoc Physicians India; 2019 Nov; 67(11):36-39. PubMed ID: 31793267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor-2 polymorphisms and iron overload in transfusion independent b-thalassemia intermedia.
    Ma ES; Lam KK; Chan AY; Ha SY; Au WY; Chan LC
    Haematologica; 2003 Mar; 88(3):345-6. PubMed ID: 12651274
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune Status 'in Children with Beta Thalassemia' in Correlation 'with Iron Overload': Single Center Egyptian Study.
    Hagag AA; Elgamsy MA; El-Asy HM; Gamal RM; Elshahaby WN; Abd Elbar ES
    Endocr Metab Immune Disord Drug Targets; 2016; 16(3):181-188. PubMed ID: 27829333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of frequency of hereditary hemochromatosis (HFE) gene mutations (H63D and C282Y) with iron overload in beta-thalassemia major patients in Pakistan.
    Sharif Y; Irshad S; Tariq A; Rasheed S; Tariq MH
    Saudi Med J; 2019 Sep; 40(9):887-892. PubMed ID: 31522215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Serum Immunoglobulin Levels and T lymphocyte Subsets in Children with Beta Thalassemia with Iron Overload in Egypt.
    Hagag AA; Elgamasy MA; Abd Elbar ES
    Egypt J Immunol; 2016 Jan; 23(1):97-105. PubMed ID: 28502157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.